Rapid Micro Biosystems (NASDAQ:RPID) Rating Increased to Hold at Wall Street Zen

Rapid Micro Biosystems (NASDAQ:RPID) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Monday.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $8.00.

Rapid Micro Biosystems Price Performance

Shares of RPID stock opened at $3.14 on Monday. The firm has a market cap of $139.16 million, a price-to-earnings ratio of -3.11 and a beta of 1.36. Rapid Micro Biosystems has a 12 month low of $0.96 and a 12 month high of $4.50. The company has a quick ratio of 2.95, a current ratio of 4.23 and a debt-to-equity ratio of 0.42. The stock has a 50-day moving average price of $3.53 and a 200 day moving average price of $3.32.

Rapid Micro Biosystems (NASDAQ:RPID) last issued its earnings results on Friday, November 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.26). The company had revenue of $7.84 million for the quarter, compared to analyst estimates of $7.60 million. Rapid Micro Biosystems had a negative net margin of 145.11% and a negative return on equity of 73.90%. Research analysts expect that Rapid Micro Biosystems will post -1.1 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. American Century Companies Inc. bought a new stake in Rapid Micro Biosystems in the 1st quarter valued at approximately $31,000. Hudson Bay Capital Management LP acquired a new stake in shares of Rapid Micro Biosystems in the third quarter valued at approximately $38,000. XTX Topco Ltd bought a new stake in shares of Rapid Micro Biosystems in the second quarter worth $144,000. Dimensional Fund Advisors LP boosted its holdings in Rapid Micro Biosystems by 37.8% during the third quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock worth $186,000 after purchasing an additional 15,255 shares during the last quarter. Finally, Susquehanna International Group LLP boosted its holdings in Rapid Micro Biosystems by 12.6% during the third quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock worth $195,000 after purchasing an additional 6,528 shares during the last quarter. 52.60% of the stock is currently owned by institutional investors.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.